Revisions to CMS guidelines on ABPM reimbursement make it the perfect time to offer 24-hour out-of-office blood pressure measurement to your patients. For more information on reimbursement, see our 2020 ABPM Reimbursement FAQ.

The US reimbursement guidelines for Ambulatory Blood Pressure Monitoring (ABPM) may change after the American Heart Association (AHA) and the American Medical Association (AMA) penned a joint letter to the Center for Medicare and Medicaid Services (CMS) requesting that CMS reconsider the current ABPM guidelines.

Gone are the days where your cardiovascular health could be summed up in two numbers. Systolic and diastolic blood pressure, measured at the brachial artery, were the key tools for staving off heart attack, stroke and other cardiovascular disease (CVD). Have a BP of under 140/90? Great! You are going to live a long and healthy life. Over 140/90? Time to watch your salt and medicate away. While lowering BP in hypertensive patients has been proven to be an effective intervention, it may not be so simple any more. Research, such as the SPRINT study, are finding benefits for managing BP in pre-hypertensive patients. With that, a new series of indices and measurements are offering more tools for doctors to measure and treat hypertension.

Ambulatory blood pressure monitoring (ABPM) - a procedure in which a patient wears an automatic blood pressure device for 24 hours as readings are taken every 30-60 minutes - is a widely used hypertension diagnostic tool in many countries, but not the US.

Traditionally, blood pressure (BP) measurement is largely confined to the doctor's office, using manual measurements to provide a snapshot of a patient's blood pressure and cardiovascular risk.